Onconova Therapeutics, Inc. (ONTX) Social Stream



Onconova Therapeutics, Inc. (ONTX): $1.01

0.04 (+4.12%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add ONTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#215 of 394

in industry

ONCONOVA THERAPEUTICS INC (ONTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ONCONOVA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-13 3 $59.97 $11 $35.485 $0.741 4688.8%
2022-05-13 4 $11 $7 $9 $0.741 1114.57%
2022-11-15 2 $11 $7 $9 $0.741 1114.57%
2023-03-17 3 $11 $7 $9 $0.741 1114.57%
2023-04-20 3 $7 $7 $7 $0.741 844.67%
2023-11-16 3 $11 $7 $8.333 $0.741 1024.56%

The Trend in the Analyst Price Target


Over the past 26 weeks, ONTX's average price target has gone down $0.

Over the past 35 weeks, ONTX's average upside potential has been 857.43%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-21 3 11 7 8.333 1.09 664.5%
2023-05-16 3 11 7 8.333 1.13 637.43%
2023-05-17 3 11 7 8.333 1.14 630.96%
2023-06-14 3 11 7 8.333 1.16 618.36%
2023-08-11 3 11 7 8.333 0.96 768.02%

ONTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 24 months, ONTX's average broker recommendation rating improved by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ONCONOVA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 685.54% of them.
  • To contextualize these metrics, consider that out of all US stocks, ONCONOVA THERAPEUTICS INC's number of analysts covering the stock is higher than 59.07% of them.
  • In the context of stocks in the small market cap category, ONCONOVA THERAPEUTICS INC's average analyst price target is greater than 264.93% of them.
  • ONCONOVA THERAPEUTICS INC's variance in analysts' estimates is lower than -188.09% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, ADXS, NWBO, and CBAY are the three stocks most similar to ONCONOVA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is ONTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!